Tight Control of Disease Activity Among Patients With RA Based on a Systematic Telemedicine Treatment Strategy

NCT02155894 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2015-07-09

No results posted yet for this study

Summary

The study aims to investigate the effect a systematic telemedicine intervention, based on the tigth control principals, as a platform for disease monitoring among patients with rheumatoid arthritis.

It is hypothesized that:

* A systematic telemedicine intervention targeted to tight control of disease activity among patients with RA will be equally effective as usual care (outpatient consultation by a rheumatologist).
* There will be no difference in the effect whether this telemedicine consultation is carried out by a rheumatologist or a rheumatology nurse.
* Patient satisfaction and the patient's general perception of involvement in their treatment will be increased for patients who receive the telemedicine intervention.
* All the effects will apply both in the short term (\< 6 months) and in the long term (\> 1 year).

Conditions

Interventions

BEHAVIORAL

Disease control, Telemedicine, doctor

Control of disease activity by a telemedicine consultation carried out by a doctor. The telemedicine consultation will be based on a telephone consultation, following a predefined consultation checklist. Patients who have expressed a desire to complete questionnaires in webform, will receive a letter a week before the consultation to remind them that they must assess their disease activity through the software interphase, within the next couple of days. Patients, who have expressed a wish to fill in questionnaires in paperform, will receive the questionnaire a week before the consultation. During telephone consultation, updated clinical test results will be available through the electronic medical system.

BEHAVIORAL

Disease control, Telemedicine, nurse

Control of disease activity by a telemedicine consultation carried out by a nurse. The telemedicine consultation will be based on a telephone consultation, following a predefined consultation checklist. Patients who have expressed a desire to complete questionnaires in webform, will receive a letter a week before the consultation to remind them that they must assess their disease activity through the software interphase, within the next couple of days. Patients, who have expressed a wish to fill in questionnaires in paperform, will receive the questionnaire a week before the consultation. During telephone consultation, updated clinical test results will be available through the electronic medical system.

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Annette de Thurah, MPH, Ph.D · Department of Rheumatology, Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2014-05-31
Completion
2015-07-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02155894 on ClinicalTrials.gov